High Rate of Reduced Susceptibility to Ciprofloxacin and Ceftriaxone among Nontyphoid Salmonella Clinical Isolates in Asia-Reference-Cited by-同舟云学术

High Rate of Reduced Susceptibility to Ciprofloxacin and Ceftriaxone among Nontyphoid Salmonella Clinical Isolates in Asia

Published:2009-06 Issue:6 Volume:53 Page:2696-2699
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Lee Hao-Yuan¹²,Su Lin-Hui¹²,Tsai Ming-Han¹²,Kim Shin-Woo³,Chang Hyun-Ha³,Jung Sook-In⁴,Park Kyung-Hwa⁴,Perera Jennifer⁵,Carlos Celia⁶,Tan Ban Hock⁷,Kumarasinghe Gamini⁷,So Thomas⁸,Chongthaleong Anan⁹,Hsueh Po-Ren¹⁰,Liu Jien-Wei¹¹,Song Jae-Hoon¹²,Chiu Cheng-Hsun¹²

Affiliation:

1. Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan

2. Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan

3. Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea

4. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea

5. University of Colombo, Colombo, Sri Lanka

6. Research Institute for Tropical Medicine, Manila, Philippines

7. Singapore General Hospital, National University of Singapore, Singapore

8. Princess Margaret Hospital, Hong Kong

9. Chulalongkorn University, Bangkok, Thailand

10. Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

11. Chang Gung Memorial Hospital, Kaohsiung, Taiwan

12. Samsung Medical Center, Seoul, Korea

Abstract

ABSTRACT This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 μg/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S . Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 μg/ml) remained uncommon in Asia, except in Taiwan (38.0%) or in S . Typhimurium (25.0%) from all countries.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01297-08

Reference14 articles.

1. Bangtrakulnonth, A., S. Pornreongwong, C. Pulsrikarn, P. Sawanpanyalert, R. S. Hendriksen, D. M. Lo Fo Wong, and F. M. Aarestrup. 2004. Salmonella serovars from humans and other sources in Thailand, 1993-2002. Emerg. Infect. Dis.10:131-136.

2. Biedenbach, D. J., M. Toleman, T. R. Walsh, and R. N. Jones. 2006. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn. Microbiol. Infect. Dis.54:13-21.

3. Cheong, H. J., Y. J. Lee, I. S. Hwang, S. Y. Kee, H. W. Cheong, J. Y. Song, J. M. Kim, Y. H. Park, J. H. Jung, and W. J. Kim. 2007. Characteristics of non-typhoidal Salmonella isolates from human and broiler-chickens in southwestern Seoul, Korea. J. Korean Med. Sci.22:773-778.

4. Chiu, C. H., T. L. Wu, L. H. Su, C. Chu, J. H. Chia, A. J. Kuo, M. S. Chien, and T. Y. Lin. 2002. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N. Engl. J. Med.346:413-419.

5. Chiu, C. H., T. L. Wu, L. H. Su, J. W. Liu, and C. Chu. 2004. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003. Emerg. Infect. Dis.10:1674-1676.

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyelonephritis with bacteremia caused by Salmonella Choleraesuis in a Japanese patient with carcinoma of unknown primary origin: A case report;Journal of Infection and Chemotherapy;2024-11

2. BolA promotes the generation of multicellular behavior in S. Typhimurium by regulating the c-di-GMP pathway genes yeaJ and yhjH;International Journal of Food Microbiology;2024-02

3. Antimicrobial Resistance in Salmonella: Its Mechanisms in Comparison to Other Microbes, and The Reversal Effects of Traditional Chinese Medicine on Its Resistance;Salmonella - Perspectives for Low-Cost Prevention, Control and Treatment;2024-01-24

4. Emergence and Distribution of Diverse Serovars of Non-Typhoidal Salmonellae in Mangalore, Coastal Karnataka: A 12-year Experience;Archives of Medicine and Health Sciences;2024-01

5. Genomic Characterization of Salmonella enterica Resistant to Cephalosporin, Quinolones, And Macrolides;Current Microbiology;2023-09-19